SCHEMBL6201202

SCHEMBL6201202

O=Cc1ccc(C(O)Cc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
CYP2A6 P11509 1/20 0.46
TYR P14679 1/20 0.44
EPHX1 P07099 2/20 0.43
CYP1A2 P05177 2/20 0.42
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SRR Q9GZT4 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ACP3 P15309 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
ALPI P09923 1/20 0.40
PKM P14618 1/20 0.40
PTGS1 P23219 1/20 0.40
XIAP P98170 1/20 0.40
SLC7A5 Q01650 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7430133 0.93 KDM4E (0.47) ALDH1A1CYP2A6EPHX1CYP1A2KDM4E
SCHEMBL8322091 0.85 RAB9A (0.55) CYP1A2PTGS1RAB9AHIF1APPARG
SCHEMBL27861277 0.83 SLC6A2 (0.53) ALDH1A1CYP2A6TYREPHX1CYP1A2
SCHEMBL230545 0.81 P4HTM (0.54) EPHX1CYP1A2SRRALPIPKM
SCHEMBL18614965 0.80 TYR (0.52) ALDH1A1CYP2A6TYREPHX1MEN1
SCHEMBL4355212 0.80 LMNA (0.58) EPHX1CYP1A2KDM4EL3MBTL1ACP3
SCHEMBL125923 0.80 LMNA (0.58) EPHX1CYP1A2KDM4EL3MBTL1ACP3
SCHEMBL29152730 0.76 TAAR1 (0.54) ALDH1A1KDM4ETAAR1TSHRNFKB1
SCHEMBL6124173 0.76 ALDH1A1 (0.54) ALDH1A1CYP2A6TYRKDM4EL3MBTL1
SCHEMBL7070372 0.76 SRR (0.40) EPHX1SRRALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed
CN-1384835-A Tricycle inhibitors of poly(ADP-ribose) polymerases AGOURON PHARMA (US) 2002-12-11 CN disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed